New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis
Background and purposeThe objective of this study is to systematically review the efficacy and safety of cilostazol-based dual antiplatelet therapy (DAPT) in patients with stroke.MethodsTwo reviewers conducted a comprehensive search of eligible studies published in PubMed, Medline, the Cochrane Libr...
Saved in:
| Main Authors: | Xiaorui Wang, Yixin Wang, Qiang Zheng, Pengwei Li, Jingli Yin, Miaomiao Wang, Liangyu Zou, Jie Wang, Jialin Pan, Lei Qin, Song Luo, Lijuan Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1533674/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01) -
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease
by: Jong Ryeol Eun, et al.
Published: (2025-05-01) -
Effect of Cilostazol on Myocardial Histomorphological Changes in Ischemia-Reperfusion Injury
by: Anar Amrah, et al.
Published: (2025-03-01) -
Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis
by: Jing Sun, et al.
Published: (2025-06-01) -
Benefits of Cilostazol’s Effect on Vascular and Neuropathic Complications Caused by Diabetes
by: Diego Castro Musial, et al.
Published: (2024-12-01)